Holen Sie sich die Stockscreener-App
2.91
9.81%
0.26
Handel nachbörslich:
2.96
0.05
+1.72%
Finanzdaten der Atossa Therapeutics Inc-Aktie (ATOS)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Operating Expenses |
11.91%
8.694
|
9.87 | 11.44 | 9.251 | 9.04 |
| Operating Income/Loss |
11.91%
-8.694
|
-9.87 | -11.44 | -9.251 | -9.04 |
| Income/Loss From Continuing Operations Before Tax |
11.45%
-8.491
|
-9.589 | -10.94 | -8.692 | -8.423 |
| Income Tax Expense/Benefit |
-
|
- | - | - | - |
| Net Income/Loss |
11.45%
-8.491
|
-9.589 | -10.94 | -8.692 | -8.423 |
| Basic Average Shares |
3.32%
8.9085
|
8.6223 | - | 129.17 | 129.17 |
| Diluted Average Shares |
3.32%
8.9085
|
8.6223 | - | 129.17 | 129.17 |
| Basic Earnings Per Share |
14.41%
-0.95
|
-1.11 | - | -0.07 | -0.07 |
| Diluted Earnings Per Share |
14.41%
-0.95
|
-1.11 | - | -0.07 | -0.07 |
4.22%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):